掃描二維碼開(kāi)始閱讀
Scan to preview the contents.
https://flbook.com.cn/c/eWk2A8AsPG
Pharma Sources Insight January 2024 focuses on the following topics:
SPONSORED BY
- XINJITAI PHARMA PACKAGING
FROM THE EDITOR
- Hope for Sickle Cell Disease Patients as Gene Therapy Gets More Approvals
GLOBAL PHARMA INDUSTRY
- Global Pharmaceutical Companies' Dream of Nuclear Medicine
- Personalized Medicine: A New Era in Healthcare
- New regulations in the Year 2023 for Different Regulatory Bodies Around the World
NEW DRUG R&D
- Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused
Worth Reading:
-Advancements in scientific technologies to Drug discovery and Development 2023
-What To Expect In The 2024 Pharmaceutical Market
- The Evolving Landscape of Heart Failure Therapies
PHARMA IN CHINA
- Looking at the New Layout of MNC in China from AstraZeneca Joining Hands with Chinese Pharmaceutical Companies Again
- Popular Products and Companies at PharmaSources.com
INDUSTRY INSIGHT
- Flexible Production in the Pharmaceutical Industry: Navigating the Dynamics of Innovation
- Case Study of FDA Warning Letters
About Pharma Sources Insight
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.
【往期回顧】
點(diǎn)擊下圖，免費閱讀往期內容
第十期：https://flbook.com.cn/c/fXXDEGvou9
第九期：https://flbook.com.cn/c/LQXB6v43Qi
Pharma Sources Insight,
Your FREE source of news and insights into China pharmaceutical industry,
and more!
合作咨詢(xún)
肖女士
021-33392297
Kelly.Xiao@imsinoexpo.com
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
